Previous 10 | Next 10 |
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova ® for the eye care market, announces the signing of an agreement with Paragon Care Group Australia Pty Ltd for the exclusive distribution of Avenova ...
Why Should You Pay Attention to These Penny Stocks Right Now? When it comes to penny stocks , finding the biggest gainers of the day can be a good step in the right direction. This allows investors to see what type of momentum a penny stock has. In addition, it can help to identify ...
NovaBay Pharmaceuticals, Inc. (NBY) Q3 2020 Earnings Conference Call Nov 12, 2020, 04:30 PM ET Company Participants Jody Cain - VP, LHA Justin Hall - President & CEO Andrew Jones - CFO & Treasurer Conference Call Participants Edward Woo - Ascendiant Capital Presentation Operator Welco...
NovaBay (NBY): Q3 GAAP EPS of -$0.08 misses by $0.04.Revenue of $2.17M (+34.0% Y/Y) misses by $0.35M.Shares -1.4%.Press Release For further details see: NovaBay EPS misses by $0.04, misses on revenue
Revenue increased 34% versus prior year Avenova ® unit sales set quarterly record Exited Q3 with $13.4 million in cash and equivalents Regained compliance with NYSE American continued-listing standards Launches CelleRx ® Clinical Res...
Company enters beauty market with the launch of Clinical Reset as an expansion of the CelleRx brand NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces the consumer launch of Clinical Reset, an FDA-cleared skincare product proven to help clean and reduce the bui...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three and nine months ended September 30, 2020 after market close on Thursday, November 12, 2020 and will hold an investment community conference call that day at 4:30 p....
NovaBay ([[NBY]] +3.2%) announces that it has regained full compliance with the NYSE listing standards after the company filed its Q2 reports.The Company was notified on April 12, 2019 that it was not in compliance with the NYSE American’s continued listing standards including the...
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces it believes that it has regained full compliance with the NYSE American’s continued listing standards, subject to NYSE American’s formal confirmation that the Company has regained compliance after...
3 Penny Stocks To Trade Or Fade Before The Opening Bell Penny stocks are high-risk/high-reward, that’s a given. But are you familiar with premarket trading? If you’re new to trading, you may not know what time the market opens. While most will start trading “...
News, Short Squeeze, Breakout and More Instantly...
NovaBay Pharmaceuticals Inc. Company Name:
NBY Stock Symbol:
NYSE Market:
NovaBay Pharmaceuticals Inc. Website:
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Ea...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova ® -branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales were 17% higher compared with Prime Day 2023 and were up 40% over ...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants f...